Human apolipoprotein E4 accelerates β-amyloid deposition in APPsw transgenic mouse brain

Annals of Neurology

Volumn 50, Issue 4, 2001, Pages 468-475

  Carter, Donald B ^a   Dunn, Edwige ^a   McKinley, Denise D ^a   Stratman, Nancy C ^a   Boyle, Timothy P ^a   Kuiper, Susan L ^a   Oostveen, Jo A ^a   Weaver, Royal J ^a   Boller, Jennifer A ^a   Gurney, Mark E ^a  

^a PFIZER INC   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

AMYLOID BETA PROTEIN; APOLIPOPROTEIN E3; APOLIPOPROTEIN E4; FORMIC ACID; THIOFLAVINE; TRANSFERRIN;

ALZHEIMER DISEASE; ANIMAL TISSUE; ARTICLE; BRAIN LEVEL; CONTROLLED STUDY; GENE MUTATION; GENETIC RISK; IMMUNOHISTOCHEMISTRY; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROGENY; PROTEIN EXPRESSION; PROTEIN LOCALIZATION; TRANSGENIC MOUSE;

AGE FACTORS; AMYLOID BETA-PROTEIN; AMYLOID BETA-PROTEIN PRECURSOR; ANIMALS; ANTIBODIES, MONOCLONAL; APOLIPOPROTEIN E4; APOLIPOPROTEINS E; BRAIN; BRAIN CHEMISTRY; GENE EXPRESSION; HUMANS; IMMUNOENZYME TECHNIQUES; LDL-RECEPTOR RELATED PROTEIN 1; MICE; MICE, INBRED C57BL; MICE, TRANSGENIC; MUTATION; PEPTIDE FRAGMENTS; RECEPTORS, IMMUNOLOGIC; SENILE PLAQUES;

EID: 0034796318     PISSN: 03645134     EISSN: None     Source Type: Journal    
DOI: 10.1002/ana.1134     Document Type: Article

References (28)

1. Alzheimer diseases: A model of gene mutations and susceptibility polymorphisms for complex psychiatric diseases
2. Association of apolipoprotein E allele epsilon 4 with late-onset familial and sporadic Alzheimer's disease
3. APOE genotype predicts when-not whether-one is predisposed to develop Alzheimer disease
4. Apolipoprotein E and Alzheimer disease
5. Increased amyloid beta-peptide deposition in cerebral cortex as a consequence of apolipoprotein E genotype in late-onset Alzheimer disease
6. Apolipoprotein E: High-avidity binding to beta-amyloid and increased frequency of type 4 allele in late-onset familial Alzheimer disease
7. Characterization of stable complexes involving apolipoprotein E and the amyloid beta peptide in Alzheimer's disease brain
8. Lack of apolipoprotein E dramatically reduces amyloid beta-peptide deposition
9. Apolipoprotein E is essential for amyloid deposition in the APP(V717F) transgenic mouse model of Alzheimer's disease
10. Expression of human apolipoprotein E reduces amyloid-beta deposition in a mouse model of Alzheimer's disease
11. Apolipoprotein E isoform-dependent amyloid deposition and neuritic degeneration in a mouse model of Alzheimer's disease
12. Discovery of a brain promoter from the human transferrin gene and its utilization for development of transgenic mice that express human apolipoprotein E alleles
13. Human ApoE protein localized in the brains of transgenic mice
14. Correlative memory deficits, Abeta elevation, and amyloid plaques in transgenic mice
15. Amyloid beta protein (A beta) in Alzheimer's disease brain. Biochemical and immunocytochemical analysis with antibodies specific for forms ending at A beta 40 or A beta 42(43)
16. The effects of age, apolipoprotein E phenotype and gender on the concentration of amyloid-beta (A beta) 40, A beta 4242, apolipoprotein E and transthyretin in human cerebrospinal fluid
17. Visualization of A beta 42(43) and A beta 40 in senile plaques with end-specific A beta monoclonals: Evidence that an initially deposited species is A beta 42(43)
18. 42 in cerebrovascular deposits
19. Apolipoprotein E facilitates neuritic and cerebrovascular plaque formation in an Alzheimer's disease model
20. Apolipoprotein E in sporadic Alzheimer's disease: Allelic variation and receptor interactions
21. Aβ - Peptide length and apolipoprotein E genotype in Alzheimer's disease
22. Apolipoprotein E genotype and deposits of Abeta40 and Abeta42 in Alzheimer disease
23. Abetal-40 but not Abetal-42 levels in cortex correlate with apolipoprotein E epsilon4 allele dosage in sporadic Alzheimer's disease
24. Detection of apolipoprotein E/dimeric soluble amyloid beta complexes in Alzheimer's disease
25. Opposite roles of apolipoprotein E in normal brains and in Alzheimer's disease
26. Lipidation of apolipoprotein E influences its isoform-specific interaction with Alzheimer's amyloid beta peptides
27. Purification of apolipoprotein E attenuates isoform-specific binding to betaamyloid
28. Characterization of the binding of amyloid-beta peptide to cell culture-derived native apolipoprotein E2, E3, and E4 isoforms and to isoforms from human plasma